Atlas Trials

IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial

Clinical trial NCT06654011 · RECRUITING

Trial details

NCT number
NCT06654011
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Cervical AdenocarcinomaGastric-type Endocervical Adenocarcinoma
Start date
2025-02-17
Primary completion
2026-05-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.